Effect of Ivabradine in Stage D HF/Cardiogenic Shock Patients on Dobutamine
Clinical trial NCT03387605 · UNKNOWN
Trial details
- NCT number
- NCT03387605
- Sponsor
- Loyola University
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-15
- Primary completion
- 2020-01-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.